Literature DB >> 2911444

Oral erythema multiforme: clinical observations and treatment of 95 patients.

F Lozada-Nur1, M Gorsky, S Silverman.   

Abstract

Erythema multiforme is a chronic, inflammatory mucocutaneous disease that can occur in both genders at any age. Although the cause remains obscure, a wide range of antigens and factors, including herpesvirus and other infections, has been suggested as triggering the disease. In the present study of 95 patients, we found that patients with oral involvement alone tend to predominate over those who have oral and lip, or oral, lip, and skin disease. There were also more women than men. Our study further confirmed that erythema multiforme cannot be characterized solely as a disease that is cyclical and self-limiting. The dramatic response to corticosteroids and to the immunoregulating agent levamisole, as well as the fact that patients with erythema multiforme are otherwise essentially healthy, suggests that erythema multiforme may be caused by a transient autoimmune defect, possibly triggered by multiple factors. Because 19 patients with oral candidiasis responded to antifungal therapy, a possible antigenic role for these organisms is suggested.

Entities:  

Mesh:

Year:  1989        PMID: 2911444     DOI: 10.1016/0030-4220(89)90299-5

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  3 in total

Review 1.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

2.  Erythema multiforme major following treatment with infliximab.

Authors:  Dean Edwards; Eli Boritz; Edward W Cowen; Ronald S Brown
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-10-01

3.  Fuchs Syndrome: Medical Treatment of 1 Case and Literature Review.

Authors:  Rémy Gossart; Eve Malthiery; Fanny Aguilar; Jacques-Henri Torres; Marie-Alix Fauroux
Journal:  Case Rep Dermatol       Date:  2017-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.